News
Today's jam-packed edition includes breaking news on a most-favored-nation drug policy and reconciliation legislation; also tariffs and an FDA-approved CRISPR pig. (843 words, 4 minutes, 12 seconds) ...
Today, we take a deep dive into what’s been happening in the state legislatures—here’s what BIO’s watching related to healthcare and agriculture. Plus, two bills designed to strengthen U.S. patents ...
Explore the webinar opportunities for interactive, online learning about emerging issues in biotechnology public policy, scientific progress, and raising capital, plus methods to benefit from BIO’s ...
"BIO is a crucial trade group representing all biotech and biopharma companies with influence on policies affecting our business and patients with rare diseases in the U.S. Through our participation ...
BIO 2025 is around the corner—and with thousands of potential partners and limited time, preparation is everything. Whether you're a first-time attendee or a seasoned BIO veteran, this webinar will ...
A busy April is flying by. Today, we look at the executive order on drug pricing, the threat of pharmaceutical tariffs, a CDC meeting on immunization practices, and BIO’s appearances at many ...
BIO launches a new campaign to explain why we vaccinate – and why it's good for America. We have details, plus how drug companies are investing in U.S. manufacturing, news on drug prices and IP, and ...
Browse the cost savings options for your organization: ...
How can BIO help you make your mark? A membership with BIO gives you a powerful voice to help advance your science and enact meaningful change.
At its simplest, biotechnology is technology based on biology - biotechnology harnesses cellular and biomolecular processes to develop technologies and products that help improve our lives and the ...
Biotechnology innovations help millions of people every day. From new treatments for patients to cleaner manufacturing to more resilient crops and livestock - biotech makes our future brighter.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results